OS4.4 Hypofractionated stereotactic radiotherapy and...

OS4.4 Hypofractionated stereotactic radiotherapy and anti-PDL1 Durvalumab combination in recurrent glioblastoma: Results of the phase I part of the phase I/II STERIMGLI trial

Pouessel, D, Mervoyer, A, Larrieu-Ciron, D, Cabarrou, B, Robert, M, Frenel, J, Olivier, P, Mounier, M, Cohen-Jonathan Moyal, E
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noz126.034
Date:
September, 2019
File:
PDF, 132 KB
english, 2019
Conversion to is in progress
Conversion to is failed